Cliniapps

India
Language translation, bio-analytical monitoring, and clinical services provided in healthcare.

About Cliniapps

Cliniapps is a Healthcare company based in India. Language translation, bio-analytical monitoring, and clinical services provided in healthcare. It operates in the Healthcare and Business Services sectors. The company has 36 employees. Its Indian entity Cliniapps Private Limited reported revenue of β‚Ή4.56 Cr. Cliniapps offers products and services including Language Translation Services and Bioequivalence Study Management. Its focus areas include Biotechnology, Bioanalytical Services, Auditing and Monitoring and Life Sciences.

Company details

CliniApps Private Limited is known for delivering language translation and bio-analytical services that support clinical research and pharmaceutical sectors. Services such as system audits for CROs, GCP and GLP training, and bioequivalence study management are provided to ensure compliance and quality. The organization is committed to community initiatives in health and environment, with a focus on timely research completion through dedicated processes. Innovation and continuous improvement are emphasized in service delivery to meet industry needs.

  • Headquarters India
  • Employees 36
  • Sectors
    Healthcare
    Business Services
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cliniapps.com
  • Social LinkedIn X Facebook
  • Legal Name Cliniapps Private Limited
  • Date of Incorporation 21 Jun, 2012
  • Jurisdiction Gujarat, India
Key Metrics
  • Annual Revenue
    ₹4.56 Cr

    FY 2024 · +18% YoY

  • Net Profit
    ₹83 Lakh

    FY 2024 · 18% margin

  • EBITDA
    ₹1.52 Cr

    FY 2024 · 33% margin

  • Employee Count
    36

Products & Services of Cliniapps

Cliniapps offers a comprehensive portfolio of products and services, including Language Translation Services and Bioequivalence Study Management.

Language Translation Services
Translation Services

Language translation services are provided using native translators for various industries, ensuring accurate solutions for translation needs

Bioequivalence Study Management
Clinical Services

Bioequivalence study management is offered to maintain study compliance and enhance success rates through expert monitoring and validation processes

Board of directors of Cliniapps Private Limited (Cliniapps)

Cliniapps Private Limited is the primary company behind Cliniapps. The board of Cliniapps Private Limited currently have 5 directors; the longest-serving is Jaimin Gunvantbhai Shah, appointed in 2012. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Jaimin Gunvantbhai Shah
DIN 05293138
Director21 Jun 201214 yrs 4 moCliniapps Private Limited
Darshit Nileshbhai Shah
DIN 05294971
Director21 Jun 201214 yrs 4 moCliniapps Private Limited
Ruchi Shailendra Gupta
DIN 05294977
Director21 Jun 201214 yrs 4 moCliniapps Private Limited
Paras Jitendrabhai Shah
DIN 05293828
Director21 Jun 201214 yrs 4 moCliniapps Private Limited
Varsha Sandeep Sharma
DIN 05305359
Director21 Jun 201214 yrs 4 moCliniapps Private Limited

Financials of Cliniapps

Figures of Cliniapps Private Limited, the primary company behind Cliniapps, for FY 2024. Revenue was ₹4.56 Cr (+18% year on year). Net profit was ₹83 Lakh (18% margin). EBITDA was ₹1.52 Cr (33% margin). Revenue has grown at a compounded annual rate of +13% over three years and +17% over five years.

  • ₹4.56 CrRevenue · FY 2024 · +18% YoY
  • ₹83 LakhNet profit · 18% margin
  • ₹1.52 CrEBITDA · 33% margin
  • ₹25 LakhPaid-up capital
  • 36Employees (provident fund records)
  • +13%Revenue CAGR, 3 years
  • +17%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cliniapps Private Limited are on its company page.

Premium access

Detailed financial statements for Cliniapps

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cliniapps

Cliniapps is headquartered in India.

Cliniapps has 36 employees.

The primary company behind Cliniapps, Cliniapps Private Limited, reported revenue of β‚Ή4.56 Cr for FY 2024, up 18% year on year.

CliniApps Private Limited is known for delivering language translation and bio-analytical services that support clinical research and pharmaceutical sectors. Services such as system audits for CROs, GCP and GLP training, and bioequivalence study management are provided to ensure compliance and quality. The organization is committed to community initiatives in health and environment, with a focus on timely research completion through dedicated processes. Innovation and continuous improvement are emphasized in service delivery to meet industry needs.

Cliniapps offers Language Translation Services and Bioequivalence Study Management.

Cliniapps operates through Cliniapps Private Limited.

The legal entities of Cliniapps currently have 5 directors, including Jaimin Gunvantbhai Shah, Darshit Nileshbhai Shah, Ruchi Shailendra Gupta and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available